High sensitivity C reactive protein level is associated with prognosis in patients with severe coronavirus disease 19 pneumonia
Vascular Investigation and Therapy · 2021
DOI: 10.4103/2589-9686.32192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Investigation and Therapy, 2021. Verfasst von Lei Zhang und 12 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: The objective of the study is to describe the association of high-sensitivity C-reactive protein (hsCRP) in patients with severe coronavirus disease-19 (COVID-19) pneumonia and determine the relationship between hsCRP, prognosis, and other factors. METHODS: The hsCRP level and other clinical data of patients with severe COVID-19 pneumonia in Tongji Hospital were retrospectively reviewed. Unpaired t -test and Mann–Whitney test were used to compare difference in data between groups. Spearman analysis was used to analyze the correlation. RESULTS: Fifty-seven patients (25 male [43.9%] and 32 female [56.1%]) were included, and their condition was monitored for 28 days. The baseline hsCRP level was 35.5 ± 81.9 mg/L, and the hsCRP level of 49 patients increased (86.0%). Moreover, 45 (78.9%) patients recovered to ordinary/mild COVID-19 pneumonia and 12 (21.1%) progressed to critical COVID-19 pneumonia or continued having severe pneumonia. In the recovered group, the hsCRP level decreased significantly ( P = 0.0023). The hsCRP level in the deteriorated group was significantly higher than that of the recovered group ( P = 0.0019 and P = 0.0004). ΔhsCRP was significantly correlated with time from onset ( P = 0.0151), prognosis ( P = 0.0151), ΔD-dimer level ( P = 0.0320), Δwhite blood cell count ( P = 0.0018), and Δneutrophil count ( P = 0.0061). CONCLUSIONS: Severe COVID-19 pneumonia is crucial to patient prognosis and manifests high hsCRP levels; decreased hsCRP level is associated with improved patient prognosis, but hsCRP level may not increase in patients with deteriorating conditions. Simultaneous increase in hsCRP and D-dimer levels may indicate risk for venous thromboembolism in COVID-19 patients.
Zitieren
APA
Zhang, L., Yu, B., Yang, L., Zhang, H., Huang, G., Tang, L., Xu, M., Zhou, J., Xiao, L., Tang, J., Liu, X., Shu, C., & Li*, X. (2021). High sensitivity C reactive protein level is associated with prognosis in patients with severe coronavirus disease 19 pneumonia. Vascular Investigation and Therapy. https://doi.org/10.4103/2589-9686.32192
Vancouver
Zhang L, Yu B, Yang L, Zhang H, Huang G, Tang L, et al. High sensitivity C reactive protein level is associated with prognosis in patients with severe coronavirus disease 19 pneumonia. Vascular Investigation and Therapy. 2021. doi:10.4103/2589-9686.32192
BibTeX
@article{Zhang2021,
author = {Zhang, Lei and Yu, Bilian and Yang, Lizhen and Zhang, Hong and Huang, Guxiang and Tang, Liang and Xu, Min and Zhou, Jienan and Xiao, Le and Tang, Jianjun and Liu, Xianling and Shu, Chang and Li*, Xin},
title = {High sensitivity C reactive protein level is associated with prognosis in patients with severe coronavirus disease 19 pneumonia},
journal = {Vascular Investigation and Therapy},
year = {2021},
doi = {10.4103/2589-9686.32192}
}
EUVIMED